Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indus Health Plus is a leading Indian preventive healthcare company that specializes in comprehensive health screenings and personalized genetic testing. The company's flagship genomics platform, DNAlytics, provides individuals with detailed insights into their genetic predispositions for various chronic conditions and nutritional needs. With a network of over 170 partner hospitals across 70+ cities, Indus Health Plus focuses on the early detection and prevention of non-communicable diseases. Dr. Priya Naikwade, the Director of Medical Operations, oversees the clinical validity and medical partnerships that drive the company's diagnostic services. The organization aims to make high-quality preventive care accessible and affordable to a broad population through technology-driven health solutions. By integrating advanced diagnostics with personalized wellness plans, Indus Health Plus empowers individuals to take proactive control of their health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Priya Naikwade.